drugset / Trial / NCT00990704
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a exploratory comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in chronic kidney disease participants receiving hemodialysis with secondary hyperparathyroidism.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paricalcitol | Other / unclassified | 2 ug | Intravenous |
| Comparator | maxacalcitol | Small molecule | 5 ug | Intravenous |
| Comparator | maxacalcitol | Small molecule | 10 ug | Intravenous |